When people think “brain health,” blood pressure rarely tops the list. It should. This is not just association: the SPRINT MIND blood-pressure trial found that targeting systolic pressure under 120 mm Hg (versus the usual under 140) cut the risk of mild cognitive impairment by about 19%. That is controlled trial evidence, the strongest kind we have for a dementia lever. SPRINT MIND is a hypertension study, not the MIND diet.
The link is explained in the brain–heart axis review, while the blood-pressure guide covers measurement technique and the practical conversation to have with a clinician. A 2026 SPRINT analysis asked the carrier-specific question directly: intensive blood pressure control and dementia risk in APOE4 carriers.
Most people do not know where they stand: Stage 1 hypertension starts at 130/80, and high blood pressure is usually symptomless. The mechanism is intuitive: chronic high pressure damages the small vessels the brain runs on. For carriers, who already carry elevated brain and vascular risk, that makes blood pressure a high-leverage, quietly powerful target.
The good news is it is measurable and treatable, through exercise (worth about 4 to 5 mm Hg on its own), diet and less sodium, weight, alcohol moderation, sleep (including ruling out apnea), and medication when needed. Start by knowing your numbers. More in the deep dive on blood pressure and brain health.